Jefferson Logo

Home > News >

News Archive from September 2007

About News Archive

Information

September 30, 2007

MicroRNAs May be Key to HIV’s Ability to Hide, Evade Drugs, Jefferson Scientists Find

Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system. Researchers at Jefferson Medical College in Philadelphia have shown that when an individual infected with HIV receives a powerful cocktail of antiviral agents called HAART (highly active antiretroviral therapy), the virus calls on miRNAs to help it remain quiet and practically undetectable, temporarily shutting down its ability to replicate and infect.

September 28, 2007

Jefferson Researchers Discover Key Regulator of Hormonal Signaling in Breast Cancer Cells, Potential Drug Target

Scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered new molecular evidence of the role of the hormone prolactin in breast cancer.

September 25, 2007

Jefferson Psychiatry Chair Named Interim Dean of Jefferson Medical College

Michael J. Vergare, M.D., the Daniel Lieberman Professor and Chair of the Department of Psychiatry and Human Behavior at Jefferson Medical College of Thomas Jefferson University, has been named interim dean of the medical school effective December 12, 2007.

September 24, 2007

Jefferson Researchers Find that Personalized Interventions are Key to Improving Colon Cancer Screening Rates

One of the best ways to encourage an individual to get screened for colorectal cancer is to use a personalized approach, according to researchers at the Kimmel Cancer Center at Jefferson and Jefferson Medical College in Philadelphia.

September 20, 2007

Jefferson Radiation Oncologists to Use Real-Time System to Help Plant “Seeds” Against Prostate Cancer

Radiation oncologists and urologists at the Kimmel Cancer Center at Jefferson and Thomas Jefferson University Hospital in Philadelphia have begun using a real-time system to implant radiation-emitting seeds in prostate cancer patients. While the system, which is made by Nucletron, a technology company based in The Netherlands, is only being used for imaging and planning purposes so far, it ultimately will help with the actual placement of the seeds.

Featured September 11, 2007

Dr. Heffelfinger Talks to 6 ABC About Cosmetic Fillers

With so many options out there to get rid of wrinkles, how do you know what's best for you? And what if you don't want to go under the knife? 6 ABC sat down with Dr. Ryan Heffelfinger of the Herbert Kean Center for Facial Aesthetics at Jefferson University Hospital to find out.

September 04, 2007

Hip Resurfacing Patients Go From Excruciating Pain to Full Activity

Late last year, hip resurfacing surgery was introduced in the United States and today, the results are extremely positive. William Hozack, M.D., an orthopaedic surgeon with the Rothman Institute at Jefferson and professor of orthopaedic surgery at Thomas Jefferson University, has performed hip resurfacing on over 25 patients, and many of them are raving about the results and “relieved to be feeling no pain."

September 04, 2007

Jefferson Immunology Researchers Halt Lethal Rabies Infection in Brain

While rabies, an ancient scourge that still kills 70,000 every year in developing countries worldwide can be combated with a series of vaccines today, it nearly is always fatal when it reaches the brain.